When it comes to how they are injected, the process is similar
"The primary factors driving growth include a broad industry focus on cardiometabolic conditions, deeper penetration of multi-condition customers, strong adoption of our GLP-1 programs and more effective enrollment campaigns," said Steven Cook, Omada's chief financial officer, during the company's full-year and fourth-quarter earnings call
Tennessee patients can choose commitment tiers offering flexibility between monthly, quarterly, or semi-annual enrollment options while maintaining consistent per-month pricing
Wegovy and Ozempic have also been shown to improve glycemic control and insulin levels
A 0.25 mg dose at 5 mg/mL is 0.05 mL, which is 5 units on a U-100 syringe
Purpose-built for physicians For older adults with diabetes, CV risk lower with SGLT2 or GLP-1 vs